Back to results
US 5,965,724 AGranted
GP 130 lacking the transmembrane domain
AssigneeApplied Research Systems ARS Holding N.V.
InventorsAndrew Sharkey, Stephen Kevin Smith, Kimberley Anne Dellow
Life of this patent
Estimating the term…
Abstract
A novel splice-variant of gp 130 is disclosed, together with DNA sequence coding for it, pharmaceutical formulations comprising it, and its use ensuring the correct development of pre-implantation embryos.
Claims3
An isolated and substantially purified DNA coding for a protein having the amino acid sequence of SEQ ID NO:4.
Dependencies are inferred from the claim text.